Concepedia

Fortuna Haviv

FH

Statistics

Publications

18

Citations

877

H-Index

14

Active since

1969

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

Fortuna Haviv is an author at Abbott Fund specializing in pharmacology, medicine, and molecular pharmacology.

Publications per year

1969–2007

18

Publications

18

3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives: inhibitors of immune complex induced inflammation

Fortuna Haviv, James D. Ratajczyk, Robert W. DeNet et al. · Journal of Medicinal Chemistry · 1988 · 164 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Thrombospondin-1 Mimetic Peptide Inhibitors of Angiogenesis and Tumor Growth: Design, Synthesis, and Optimization of Pharmacokinetics and Biological Activities

Fortuna Haviv, Michael F. Bradley, Douglas Kalvin et al. · Journal of Medicinal Chemistry · 2005 · 138 citations

Pharmacy, Medicinal Chemistry, Pharmacokinetics +14

Inhibition of tumor growth by systemic treatment with thrombospondin‐1 peptide mimetics

Frank Reiher, Olga V. Volpert, Benilde Jiménez et al. · International Journal of Cancer · 2002 · 127 citations · Full text

Medicine, Oncology, Pharmacology +16

Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonists

Fortuna Haviv, Timothy D. Fitzpatrick, Rolf E. Swenson et al. · Journal of Medicinal Chemistry · 1993 · 97 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Preclinical Evaluation of Antiangiogenic Thrombospondin-1 Peptide Mimetics, ABT-526 and ABT-510, in Companion Dogs with Naturally Occurring Cancers

Anthony Rusk, Evelyn McKeegan, Fortuna Haviv et al. · Clinical Cancer Research · 2006 · 77 citations

Medicine, Oncology, Pharmacology +13

1–5 of 18